{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:06:45Z","timestamp":1762542405483},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3704","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T09:17:59Z","timestamp":1430299079000},"page":"3061-3066","source":"Crossref","is-referenced-by-count":18,"title":["Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma"],"prefix":"10.3892","volume":"12","author":[{"given":"DUQUN","family":"CHEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUCHI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZUHU","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YIFAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENGMING","family":"SU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANGCHAO","family":"NI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHANGQI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAOTING","family":"GUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YONGQING","family":"LAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"key20180108022035_b1-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180108022035_b2-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eururo.2005.03.004","article-title":"Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma","volume":"48","author":"Hofmann","year":"2005","journal-title":"Eur Urol"},{"key":"key20180108022035_b3-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-4598-8-20","article-title":"From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma","volume":"8","author":"Arsanious","year":"2009","journal-title":"Mol Cancer"},{"key":"key20180108022035_b4-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jso.20448","article-title":"Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy","volume":"94","author":"Wood","year":"2006","journal-title":"J Surg Oncol"},{"key":"key20180108022035_b5-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108022035_b6-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7257\/1053-816X.2012.32.4.182","article-title":"Renal cell carcinoma: a reappraisal","volume":"32","author":"Patel","year":"2012","journal-title":"Urol Nurs"},{"key":"key20180108022035_b7-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-13-1351","article-title":"Molecular biomarkers in advanced renal cell carcinoma","volume":"20","author":"Maroto","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180108022035_b8-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16\u20131 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ"},{"key":"key20180108022035_b9-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/bjc.2011.401","article-title":"miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215","volume":"105","author":"White","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180108022035_b10-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-4598-6-60","article-title":"OncomiRs: the discovery and progress of microRNAs in cancers","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"key20180108022035_b11-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0973-1482.95166","article-title":"Microarrays and cancer diagnosis","volume":"8","author":"Tiwari","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"key20180108022035_b12-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/978-0-387-39978-2_8","article-title":"Microarrays for cancer diagnosis and classification","volume":"593","author":"Perez-Diez","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180108022035_b13-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","article-title":"MicroRNA function in cancer: oncogene or a tumor suppressor?","volume":"28","author":"Shenouda","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"key20180108022035_b14-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.ejca.2013.06.002","article-title":"Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma","volume":"49","author":"Koberle","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180108022035_b15-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yexmp.2012.10.005","article-title":"Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma","volume":"94","author":"Zhao","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"key20180108022035_b16-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/0008-5472.CAN-09-3153","article-title":"Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection","volume":"70","author":"Patnaik","year":"2010","journal-title":"Cancer Res"},{"key":"key20180108022035_b17-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/bcr3464","article-title":"MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer","volume":"15","author":"Guo","year":"2013","journal-title":"Breast Cancer Res"},{"key":"key20180108022035_b18-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s13277-013-0928-3","article-title":"MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma","volume":"34","author":"Yu","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180108022035_b19-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3892\/etm.2011.411","article-title":"miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes","volume":"3","author":"Chen","year":"2012","journal-title":"Exp Ther Med"},{"key":"key20180108022035_b20-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<992::AID-CNCR26>3.0.CO;2-Q","article-title":"TNM staging of renal cell carcinoma: Workgroup No. 3 Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)","volume":"80","author":"Guinan","year":"1997","journal-title":"Cancer"},{"key":"key20180108022035_b21-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"key20180108022035_b22-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2011.04.110","article-title":"miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation","volume":"186","author":"White","year":"2011","journal-title":"J Urol"},{"key":"key20180108022035_b23-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1752-0509-4-51","article-title":"Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma","volume":"4","author":"Liu","year":"2010","journal-title":"BMC Syst Biol"},{"key":"key20180108022035_b24-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1479-5876-10-103","article-title":"Novel classes of non-coding RNAs and cancer","volume":"10","author":"Sana","year":"2012","journal-title":"J Transl Med"},{"key":"key20180108022035_b25-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2199-8-79","article-title":"Prediction and preliminary validation of oncogene regulation by miRNAs","volume":"8","author":"Koscianska","year":"2007","journal-title":"BMC Mol Biol"},{"key":"key20180108022035_b26-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1101\/gr.098046.109","article-title":"Reprogramming of miRNA networks in cancer and leukemia","volume":"20","author":"Volinia","year":"2010","journal-title":"Genome Res"},{"key":"key20180108022035_b27-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-07-6639","article-title":"microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma","volume":"68","author":"Kefas","year":"2008","journal-title":"Cancer Res"},{"key":"key20180108022035_b28-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ccr.2012.02.019","article-title":"VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma","volume":"21","author":"Mikhaylova","year":"2012","journal-title":"Cancer Cell"},{"key":"key20180108022035_b29-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"e37366","DOI":"10.1371\/journal.pone.0037366","article-title":"microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion","volume":"7","author":"Dey","year":"2012","journal-title":"PLoS One"},{"key":"key20180108022035_b30-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2011.04.110","article-title":"miRNA profiling for clear cell renal cell carcinoma: Biomarker discovery and identification of potential controls and consequences of miRNA dysregulation","volume":"186","author":"White","year":"2011","journal-title":"J Urol"},{"key":"key20180108022035_b31-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1752-0509-4-51","article-title":"Identifying mRNA targets of microRNA dysregulated in cancer: With application to clear cell renal cell carcinoma","volume":"4","author":"Liu","year":"2010","journal-title":"BMC Syst Biol"},{"key":"key20180108022035_b32-mmr-12-02-3061","first-page":"490","article-title":"Akt kinase: a key regulator of metabolism and progression of tumors","volume":"64","author":"Krzeslak","year":"2010","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"key20180108022035_b33-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.cellsig.2013.03.025","article-title":"Cell survival and metastasis regulation by Akt signaling in colorectal cancer","volume":"25","author":"Agarwal","year":"2013","journal-title":"Cell Signal"},{"key":"key20180108022035_b34-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2010.12.005","article-title":"Expression and prognostic relevance of the death receptor CD95 (Fas\/APO1) in renal cell carcinomas","volume":"301","author":"Macher-Goeppinger","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180108022035_b35-mmr-12-02-3061","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000334453","article-title":"Fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy","volume":"88","author":"Sejima","year":"2012","journal-title":"Urol Int"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3704\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T03:55:26Z","timestamp":1566618926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,29]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3704"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3704","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}